openPR Logo
Press release

At A CAGR Of 13.69% Global Pneumococcal Vaccine Industry Will Grow Steadily During The Period 2016-2020

02-23-2017 03:26 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Pneumococcal Vaccine

Researchmoz added Most up-to-date research on "Global Pneumococcal Vaccine Market 2016-2020" to its huge collection of research reports.

Pneumococcus (Streptococcus pneumoniae), a pathogenic bacterium, is the leading cause of serious illness worldwide. It is the major cause of pneumonia, blood infections, meningitis, sinusitis, and middle ear infections (otitis media). Pneumococcal infections affect children younger than five years and older people (65 years and older), and it is among the leading infectious disease. It kills almost 1.6 million people (including over 800,000 children under five years) every year. It can be prevented by vaccination and involves the introduction of a dead or weakened antigen into the human body. This produces lymphocytes to counter the infection and any future invasions by that antigen.

Technavios analysts forecast the global pneumococcal vaccine market to grow at a CAGR of 13.69% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global pneumococcal vaccine market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of vaccines used to prevent pneumococcal infections.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=775742

Technavio's report, Global Pneumococcal Vaccine Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
GlaxoSmithKline (GSK)
Merck
Pfizer
Sanofi

Other prominent vendors
Abera
AstraZeneca
Baxter
Beijing Minhai Biotechnology
Biken
Biogen
Celgene
Eli Lilly
Genentech
Genocea Biosciences
ImmunoBiology
Lupin
Nuron Biotech
Panacea Biotec (India)
S K Chemicals
Serum Institute of India
Sinovac
Valneva Austria

Market driver
Inclusion in NIP
For a full, detailed list, view our report

Market challenge
Inadequate vaccine coverage
For a full, detailed list, view our report

Market trend
Expansion of marketing territories
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=775742

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release At A CAGR Of 13.69% Global Pneumococcal Vaccine Industry Will Grow Steadily During The Period 2016-2020 here

News-ID: 447516 • Views:

More Releases from Pneumococcal Vaccine

Global Pneumococcal Vaccine Market Report 2019 Companies included Pfizer, GSK, MSD, Sanofipasteur, CDIBP and Others
Global Pneumococcal Vaccine Market Report 2019 Companies included Pfizer, GSK, M …
Market Reports Company has recently published 7th edition of Pneumococcal Vaccine Market Report which covers historic data of year 2013 to 2018 along with a forecast till year 2026. For inquiry or free sample pages email us at: sales@marketreportscompany.com The report provides a comprehensive view on the current state and future prospects of the market which analyzes different strategies for business growth. The global Pneumococcal Vaccine market was valued at USD xx
Global Pneumococcal Vaccine Market to grow at a CAGR of 13.69% during 2016-2020
About Pneumococcus Pneumococcus (Streptococcus pneumoniae), a pathogenic bacterium, is the leading cause of serious illness worldwide. It is the major cause of pneumonia, blood infections, meningitis, sinusitis, and middle ear infections (otitis media). Pneumococcal infections affect children younger than five years and older people (65 years and older), and it is among the leading infectious disease. It kills almost 1.6 million people (including over 800,000 children under five years) every year.

More Releases for Biotec

Beta Glucan Market Business Growth 2025 -2032 Sales, Growing Strategies |Associa …
Global beta glucan market was valued at US$ 551.4 Mn in 2022, exhibiting a CAGR of 8% in terms of revenue, over the forecast period (2023 to 2030) to reach US$ 1,020.6 Mn by 2030. The latest study, titled Beta Glucan Market 2025, published by Coherent Market Insights, offers valuable insights into regional and global markets expected to grow between 2025 and 2032. This comprehensive research examines evolving market dynamics, value
07-12-2024 | Chemicals & Materials
CMI
Beta Glucan Market Growth Will Be Extreme in the Next Years 2024 - 2031 | Associ …
Market Overview: Global beta glucan market was valued at US$ 551.4 Mn in 2022, exhibiting a CAGR of 8% in terms of revenue, over the forecast period (2023 to 2030) to reach US$ 1,020.6 Mn by 2030. Market Dynamics: The beta glucan market is witnessing high growth owing to increased health benefits and multifunctional properties of beta glucan. Beta glucan helps support digestive health, heart health, skin health, weight management and immune function.
Biopolymers Market Is Booming So Rapidly | Amyris, Kraton, Biotec
The Biopolymers Market 2024 Report makes available the current and future technical and financial analysis of the industry. It is one of the most comprehensive and important additions to the USD Analytics archive of market research studies. It offers detailed research and analysis of key aspects of the global Biopolymers market. This global report explores the key factors affecting the growth of the dynamic Biopolymers market, including the demand-supply scenario,
Beta Glucan Market Development Strategy, Sales Revenue And Progresses for Huge P …
Global beta glucan market was valued at US$ 551.4 Mn in 2022, exhibiting a CAGR of 8% in terms of revenue, over the forecast period (2023 to 2030) to reach US$ 1,020.6 Mn by 2030. Beta glucan is a natural ingredient that is used to provide texture to baked food products. It is a fiber and enhances the nutritional value and dietary fiber content of food products. Moreover, it acts
Pneumonia Vaccine Market is Generating Revenue of $10.21 Billion by 2025 | Panac …
Surge in prevalence of pneumonia across the globe, rise in government focus on immunization programs for pneumonia, and increase in focus for novel pneumococcal vaccines drive the growth of the global pneumonia vaccines market The global pneumonia vaccines market generated $7.08 billion in 2017, and is expected to reach $10.21 billion by 2025, growing at a CAGR of 5% from 2018 to 2025. Download Detailed COVID-19 Impact Sample Report at @ https://www.alliedmarketresearch.com/request-for-customization/2730?reqfor=covid COVID-19
Beta-Glucan Market Key Players Associated British Foods Plc., Biotec Pharmacon A …
Recent Developments Tate & Lyle PLC (Tate & Lyle), a leading global provider of food ingredients and solutions, has achieved Non-GMO Project verification for its PromOat Beta Glucan and PrOatein Oat Protein ingredients. The Non-GMO Project is a nonprofit organization committed to preserving and building sources of non-GMO products, educating consumers and providing verified non-GMO options under the belief that everyone deserves an informed choice about whether or not to consume food